[ad_1]
Three major organizations of Alzheimer's disease have joined forces to face the growing public health crisis. The Alzheimer's Association, the Global Brain Health Institute (GBHI) and the Alzheimer Society of the United Kingdom have joined forces to support emerging scientists in the areas of brain health and dementia through a funding program Competitive – Drivers for Global Leaders in Brain Health.
The scholarships will fund early research projects aimed at discovering prevention strategies and improving the care and support available to people with Alzheimer's disease and other types of dementia around the world. The beneficiaries are outstanding researchers and professionals whose activities are expected to have a real impact.
The pilot projects funded in 2018 include the impact of displacement and trauma on the brain health of Syrian refugees, substance abuse and brain health, music and dementia, palliative care, hearing loss and dementia. sleep and brain formation.
With strong evidence to guide them, the pilot projects address disparities in access to treatment to improve the way care is delivered to aging vulnerable populations. They seek to improve the diagnosis, treatment and care of dementia for people with dementia and their families. Researchers will explore new ways to create social change to reduce stigma and inspire seniors with optimism and dignity. The projects will also develop and refine brain health policies through evidence-based advocacy and advocacy and advance the field of brain health and dementia prevention.
Twenty-one pilot projects have been awarded in 10 countries, including Brazil, Colombia, Cuba, Greece, Ireland, Israel, Mexico, Turkey, the United Kingdom and the United States. The total funding awarded raises to more than half a million US dollars. The grants of $ 25,000 each allow the winners to test a project and, if successful, to seek additional funds from other sources to develop their work.
"The Alzheimer's Association shares the commitment of collaborating organizations to advance discovery and train the next generation of brain health leaders," said Maria C. Carillo, Ph.D., Scientific Manager, Association Alzheimer. "Dementia is an urgent global health issue, and these pilots are a positive step in finding solutions to delay or prevent Alzheimer's disease and other dementias, as well as to improve care and treatment. quality of life for people with the disease. "
Victor Valcour, executive director of the Global Brain Health Institute, said, "Our primary goal at GBHI is to protect aging populations around the world from threats to brain health by training the next generation of global leaders. not get the same level of impact – without our partnerships with the Alzheimer's Association and the Alzheimer's Society UK. "
Dr. James Pickett, head of research at the Alzheimer Society of the United Kingdom, said, "We know that people with dementia often do not receive the good quality end-of-life care they are entitled to. That's why we're funding these important innovations.The Alzheimer Society is proud to partner with the Alzheimer's Association and the World Institute of Brain Health to provide funding for outstanding dementia researchers. Research will benefit people affected by dementia around the world and we are delighted that our two UK researchers in this program are highlighting new ways to improve end-of-life dementia care. "
According to Alzheimer's Disease International, about 50 million people worldwide would be affected by dementia by 2018. That number is expected to reach 152 million by 2050. Much of this increase will occur in developing countries. development. Already 58% of people with dementia live in low- and middle-income countries. By 2050, this percentage will increase to 68%.
According to the Facts & Figures report on Alzheimer's Disease published by the Alzheimer's Association in 2018:
- An estimated 5.7 million Americans live with Alzheimer 's dementia in 2018.
- By 2025, that is in just seven years, the number of people aged 65 and over with Alzheimer's dementia is expected to reach 7.1 million.
- With no medical breakthrough, the number of people aged 65 and older with Alzheimer 's dementia could almost triple to reach 13.8 million by 2050.
- The total cost of care for people with Alzheimer's disease and other dementias in the United States is estimated at $ 277 billion (excluding unpaid care) in 2018.
- $ 186 billion represents the cost for Medicare and Medicaid; Out-of-pocket expenditures represent $ 60 billion of total payments, while other costs total $ 30 billion.
###
Warning: AAAS and EurekAlert! are not responsible for the accuracy of the news releases published on EurekAlert! contributing institutions or for the use of any information via the EurekAlert system.
Source link
